Napolitano M., Caso F., Scarpa R., Megna M., Patrì A., Balato N., Costa L. Psoriatic arthritis and psoriasis: differential diagnosis. Clin Rheumatol. 2016;35(8):1893–1901. https://doi.org/10.1007/s10067-016-3295-9..
DOI: 10.1007/s10067-016-3295-9

Lebwohl M. Psoriasis. Lancet. 2003;361(9364):1197–1204. https://doi.org/10.1016/S0140-6736(03)12954-6..
DOI: 10.1016/S0140-6736(03)12954-6

Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26(2 Suppl.):3–11. https://doi.org/10.1111/j.1468-3083.2011.04410.x..
DOI: 10.1111/j.1468-3083.2011.04410.x

Napolitano M., Megna M., Monfrecola G. Insulin resistance and skin diseases. ScientificWorldJournal. 2015;479354. https://doi.org/10.1155/2015/479354..
DOI: 10.1155/2015/479354

Lønnberg A.S., Skov L. Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Rev Clin Immunol. 2017;13(1):27–34. https://doi.org/10.1080/1744666X.2016.1213631..
DOI: 10.1080/1744666X.2016.1213631

Azfar R.S., Gelfand J.M. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol. 2008;20(4):416–422. https://doi.org/10.1097/BOR.0b013e3283031c99..
DOI: 10.1097/BOR.0b013e3283031c99

Barrea L., Macchia P.E., Di Somma C., Napolitano M., Balato A., Falco A. et al. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome. J Transl Med. 2016;14(1):130. https://doi.org/10.1186/s12967-016-0889-6..
DOI: 10.1186/s12967-016-0889-6

Devaraj S., Jialal G., Cook T., Siegel D., Jialal I. Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm Metab Res. 2011;43(1):72–74. https://doi.org/10.1055/s-0030-1268485..
DOI: 10.1055/s-0030-1268485

Muscogiuri G., Orio F., Colao A. Letter to the Editor: Vitamin D: a Wonder Drug for the Cure of Type 2 Diabetes? J Clin Endocrinol Metab. 2016;101(4):L43–L44. https://doi.org/10.1210/jc.2016-1342..
DOI: 10.1210/jc.2016-1342

Qi D., Nie X., Cai J. The effect of vitamin D supplementation on hypertension in non-CKD populations: a systemic review and meta-analysis. Int J Cardiol. 2017;227:177–186. https://doi.org/10.1016/j.ijcard.2016.11.040..
DOI: 10.1016/j.ijcard.2016.11.040

Orgaz-Molina J., Magro-Checa C., Arrabal-Polo M.A., Raya-Álvarez E., Naranjo R., Buendía-Eisman A., Arias-Santiago S. Association of 25-hydroxyvitamin D with metabolic syndrome in patients with psoriasis: a case-control study. Acta Derm Venereol. 2014;94(2):142–145. https://doi.org/10.2340/00015555-1642..
DOI: 10.2340/00015555-1642

Holick M.F. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. https://doi.org/10.1056/NEJMra070553..
DOI: 10.1056/NEJMra070553

Kovács S., Wilkens M.R., Liesegang A. Influence of UVB exposure on the vitamin D status and calcium homoeostasis of growing sheep and goats. J Anim Physiol Anim Nutr (Berl). 2015;99(1 Suppl.):1–12. https://doi.org/10.1111/jpn.12311..
DOI: 10.1111/jpn.12311

Gniadecki R. Stimulation versus inhibition of keratinocyte growth by 1,25-Dihydroxyvitamin D3: dependence on cell culture conditions. J Invest Dermatol. 1996;106(3):510–516. https://doi.org/10.1111/1523-1747.ep12343866..
DOI: 10.1111/1523-1747.ep12343866

Autier P., Boniol M., Pizot C., Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76–89. https://doi.org/10.1016/S2213-8587(13)70165-7..
DOI: 10.1016/S2213-8587(13)70165-7

Theodoratou E., Tzoulaki I., Zgaga L., Ioannidis J.P. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035. https://doi.org/10.1136/bmj.g2035..
DOI: 10.1136/bmj.g2035

Kechichian E., Ezzedine K. Vitamin D and the Skin: An Update for Dermatologists. Am J Clin Dermatol. 2018;19(2):223–235. https://doi.org/10.1007/s40257-017-0323-8..
DOI: 10.1007/s40257-017-0323-8

Van der Schaft J., Ariens L.F., Bruijnzeel-Koomen C.A., de Bruin-Weller M.S. Serum vitamin D status in adult patients with atopic dermatitis: Recommendations for daily practice. J Am Acad Dermatol. 2016;75(6): 1257–1259. https://doi.org/10.1016/j.jaad.2016.07.035..
DOI: 10.1016/j.jaad.2016.07.035

Bergler-Czop B., Brzezińska-Wcisło L. Serum vitamin D level – the effect on the clinical course of psoriasis. Postepy Dermatol Alergol. 2016;33(6):445–449. https://doi.org/10.5114/ada.2016.63883..
DOI: 10.5114/ada.2016.63883

Mattozzi C., Paolino G., Richetta A.G., Calvieri S. Psoriasis, vitamin D and the importance of the cutaneous barrier’s integrity: An update. J Dermatol. 2016;43(5):507–514. https://doi.org/10.1111/1346-8138.13305..
DOI: 10.1111/1346-8138.13305

Wadhwa B., Relhan V., Goel K., Kochhar A.M., Garg V.K. Vitamin D and skin diseases: a review. Indian J Dermatol Venereol Leprol. 2015;81(4):344–355. https://doi.org/10.4103/0378-6323.159928..
DOI: 10.4103/0378-6323.159928

Soleymani T., Hung T., Soung J. The role of vitamin D in psoriasis: a review. Int J Dermatol. 2015;54(4):383–392. https://doi.org/10.1111/ijd.12790..
DOI: 10.1111/ijd.12790

Gisondi P., Rossini M., Di Cesare A., Idolazzi L., Farina S., Beltrami G. et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166(3):505–510. https://doi.org/10.1111/j.1365-2133.2011.10699.x..
DOI: 10.1111/j.1365-2133.2011.10699.x

Orgaz-Molina J., Buendía-Eisman A., Arrabal-Polo M.A., Ruiz J.C., Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67(5):931–938. https://doi.org/10.1016/j.jaad.2012.01.040..
DOI: 10.1016/j.jaad.2012.01.040

El-Moaty Zaher H.A., El-Komy M.H.M., Hegazy R.A., Mohamed El Khashab H.A., Ahmed H.H. Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients. J Am Acad Dermatol. 2013;69(5):840–842. https://doi.org/10.1016/j.jaad.2013.07.026..
DOI: 10.1016/j.jaad.2013.07.026

Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N Engl J Med. 2009;361(5): 496–509. https://doi.org/10.1056/NEJMra0804595..
DOI: 10.1056/NEJMra0804595

Tokuyama M., Mabuchi T. New Treatment Addressing the Pathogenesis of Psoriasis. Int J Mol Sci. 2020;21(20):7488. https://doi.org/10.3390/ijms21207488..
DOI: 10.3390/ijms21207488

Hosomi J., Hosoi J., Abe E., Suda T., Kuroki T. Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology. 1983;113(6):1950–1957. https://doi.org/10.1210/endo-113-6-1950..
DOI: 10.1210/endo-113-6-1950

Bikle D.D., Gee E., Pillai S. Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol. 1993;101(5):713–718. https://doi.org/10.1111/1523-1747.ep12371681..
DOI: 10.1111/1523-1747.ep12371681

Lehmann B., Querings K., Reichrath J. Vitamin D and skin: new aspects for dermatology. Exp Dermatol. 2004;13(4 Suppl.):11–15. https://doi.org/10.1111/j.1600-0625.2004.00257.x..
DOI: 10.1111/j.1600-0625.2004.00257.x

Ellison T.I., Smith M.K., Gilliam A.C., MacDonald P.N. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol. 2008;128(10):2508–2517. https://doi.org/10.1038/jid.2008.131..
DOI: 10.1038/jid.2008.131

Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. 2007;16(7):618–625. https://doi.org/10.1111/j.1600-0625.2007.00570.x..
DOI: 10.1111/j.1600-0625.2007.00570.x

Barrea L., Savanelli M.C., Di Somma C., Napolitano M., Megna M., Colao A., Savastano S. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord. 2017;18(2):195–205. https://doi.org/10.1007/s11154-017-9411-6..
DOI: 10.1007/s11154-017-9411-6

Visconti B., Paolino G., Carotti S., Pendolino A.L., Morini S., Richetta A.G., Calvieri S. Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin. J Eur Acad Dermatol Venereol. 2015;29(10):2038–2042. https://doi.org/10.1111/jdv.12736..
DOI: 10.1111/jdv.12736

Mason A., Mason J., Cork M., Hancock H., Dooley G. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J Am Acad Dermatol. 2013;69(5):799–807. https://doi.org/10.1016/j.jaad.2013.06.027..
DOI: 10.1016/j.jaad.2013.06.027

Gisondi P., Fostini A.C., Fossà I., Girolomoni G., Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21–28. https://doi.org/10.1016/j.clindermatol.2017.09.005..
DOI: 10.1016/j.clindermatol.2017.09.005

Furue M., Tsuji G., Chiba T., Kadono T. Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin. Intern Med. 2017;56(13):1613–1619. https://doi.org/10.2169/internalmedicine.56.8209..
DOI: 10.2169/internalmedicine.56.8209

Puig L., Kirby B., Mallbris L., Strohal R. Psoriasis beyond the skin: a review of the literature on cardiometabolic and psychological co-morbidities of psoriasis. Eur J Dermatol. 2014;24(3):305–311. https://doi.org/10.1684/ejd.2014.2299..
DOI: 10.1684/ejd.2014.2299

Takahashi H., Iizuka H. Psoriasis and metabolic syndrome. J Dermatol. 2012;39(3):212–218. https://doi.org/10.1111/j.1346-8138.2011.01408.x..
DOI: 10.1111/j.1346-8138.2011.01408.x

Rodríguez-Zúñiga M.J.M., García-Perdomo H.A. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol. 2017;77(4):657–666.e8. https://doi.org/10.1016/j.jaad.2017.04.1133..
DOI: 10.1016/j.jaad.2017.04.1133

Singh S., Young P., Armstrong A.W. An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies. PLoS ONE. 2017;12(7):e0181039. https://doi.org/10.1371/journal.pone.0181039..
DOI: 10.1371/journal.pone.0181039

Уфимцева М.А., Попов А.А., Федотова Л.В., Мыльникова Е.С., Бочкарев Ю.М., Жунисова Д.С. Псориаз и метаболический синдром: обзор литературы. Ожирение и метаболизм. 2020;17(4):369–374. https://doi.org/10.14341/omet12517..
DOI: 10.14341/omet12517

Лыкова С.Г., Спицына А.В., Моржанаева М.А. Метаболический синдром и псориаз как коморбидные состояния. Дальневосточный медицинский журнал. 2017;(1):93–98. Режим доступа: http://eport.fesmu.ru/dmj/20171/2017124.aspx.http://eport.fesmu.ru/dmj/20171/2017124.aspx

Лыкова С.Г., Спицына А.В., Моржанаева М.А. Метаболический синдром и псориаз как коморбидные состояния. Дальневосточный медицинский журнал. 2017;(1):93–98. Режим доступа: http://eport.fesmu.ru/dmj/20171/2017124.aspx.http://eport.fesmu.ru/dmj/20171/2017124.aspx

Расин М.С. Хроническое воспаление, инсулинорезистентность, псориаз – что общего? Вестник дерматологии и венерологии. 2016;92(5):20–24. Режим доступа: https://www.vestnikdv.ru/jour/article/viewFile/265/266.https://www.vestnikdv.ru/jour/article/viewFile/265/266

Расин М.С. Хроническое воспаление, инсулинорезистентность, псориаз – что общего? Вестник дерматологии и венерологии. 2016;92(5):20–24. Режим доступа: https://www.vestnikdv.ru/jour/article/viewFile/265/266.https://www.vestnikdv.ru/jour/article/viewFile/265/266

Boehncke S., Thaci D., Beschmann H., Ludwig R.J., Ackermann H., Badenhoop K., Boehncke W.H. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157(6):1249–1251. https://doi.org/10.1111/j.1365-2133.2007.08190.x..
DOI: 10.1111/j.1365-2133.2007.08190.x

Kothiwala S.K., Khanna N., Tandon N., Naik N., Sharma V.K., Sharma S., Sreenivas V. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: a hospital-based cross-sectional study. Indian J Dermatol Venereol Leprol. 2016;82(5):510–518. https://doi.org/10.4103/0378-6323.183638..
DOI: 10.4103/0378-6323.183638

Uczniak S., Gerlicz Z.A., Kozłowska M., Kaszuba A. Presence of selected metabolic syndrome components in patients with psoriasis vulgaris. Postepy Dermatol Alergol. 2016;33(2):114–119. https://doi.org/10.5114/ada.2016.59153..
DOI: 10.5114/ada.2016.59153

Донцова Е.В., Олисова О.Ю., Круглова Л.С. Псориаз и метаболический синдром: механизмы коморбидности. Медицинский алфавит. 2019;1(7):34–38. https://doi.org/10.33667/2078-5631-2019-1-7(382)-34-38..
DOI: 10.33667/2078-5631-2019-1-7(382)-34-38

Кочергин Н., Смирнова Л., Потекаев Н., Билалова У. Псориаз: коморбидности и комедикации. Врач. 2009;(5):15–20. Режим доступа: https://www.elibrary.ru/item.asp?id=12415683.https://www.elibrary.ru/item.asp?id=12415683

Кочергин Н., Смирнова Л., Потекаев Н., Билалова У. Псориаз: коморбидности и комедикации. Врач. 2009;(5):15–20. Режим доступа: https://www.elibrary.ru/item.asp?id=12415683.https://www.elibrary.ru/item.asp?id=12415683

Li K., Armstrong A.W. a review of health outcomes in patients with psoriasis. Dermatol Clin. 2012;30(1):61–72. https://doi.org/10.1016/j.det.2011.08.012..
DOI: 10.1016/j.det.2011.08.012

Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271. https://doi.org/10.1016/S0140-6736(07)61128-3..
DOI: 10.1016/S0140-6736(07)61128-3

Зайдиева Я.З., Балан В.Е., Царькова А.В. Витамин D улучшает профиль риска метаболического синдрома у женщин в постменопаузе. Медицинский алфавит. 2020;(16):31–38. https://doi.org/10.33667/2078-5631-2020-16-31-38..
DOI: 10.33667/2078-5631-2020-16-31-38

Holick M.F. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–78. https://doi.org/10.1016/j.annepidem.2007.12.001..
DOI: 10.1016/j.annepidem.2007.12.001

Дедов И.И., Мазурина Н.В., Огнева Н.А., Трошина Е.А., Рожинская Л.Я., Яшков Ю.И. Нарушения метаболизма витамина D при ожирении. Ожирение и метаболизм. 2011;8(2):3–10. https://doi.org/10.14341/2071-8713-4946..
DOI: 10.14341/2071-8713-4946

Егшатян Л.В., Дудинская Е.Н., Ткачева О.Н., Каштанова Д.А. Роль витамина D в патогенезе хронических неинфекционных заболеваний. Остеопороз и остеопатии. 2014;17(3):27–30. https://doi.org/10.14341/osteo2014327-30..
DOI: 10.14341/osteo2014327-30

Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174–1180. https://doi.org/10.1001/archinte.168.11.1174..
DOI: 10.1001/archinte.168.11.1174

Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K. et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–511. https://doi.org/10.1161/CIRCULATIONAHA.107.706127..
DOI: 10.1161/CIRCULATIONAHA.107.706127

Walsh K. Adipokines, myokines and cardiovascular disease. Circ J. 2009;73(1):13–18. https://doi.org/10.1253/circj.cj-08-0961..
DOI: 10.1253/circj.cj-08-0961

Lee P., Greenfield J.R., Seibel M.J., Eisman J.A., Center J.R. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med. 2009;122(11):1056–1060. https://doi.org/10.1016/j.amjmed.2009.06.008..
DOI: 10.1016/j.amjmed.2009.06.008

Плещева А.В., Пигарова Е.А., Дзеранова Л.К. Витамин D и метаболизм: факты, мифы и предубеждения. Ожирение и метаболизм. 2012;9(2):33–42. https://doi.org/10.14341/omet2012233-42..
DOI: 10.14341/omet2012233-42

Malone M. Recommended nutritional supplements for bariatric surgery patients. Ann Pharmacother. 2008;42(12):1851–1858. https://doi.org/10.1345/aph.1L321..
DOI: 10.1345/aph.1L321

Compher C.W., Badellino K.O., Boullata J.I. Vitamin D and the bariatric surgical patient: a review. Obes Surg. 2008;18(2):220–224. https://doi.org/10.1007/s11695-007-9289-6..
DOI: 10.1007/s11695-007-9289-6

Yasue S., Masuzaki H., Okada S., Ishii T., Kozuka C., Tanaka T. et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens. 2010;23(4):425–431. https://doi.org/10.1038/ajh.2009.263..
DOI: 10.1038/ajh.2009.263

Vaidya A., Forman J.P., Underwood P.C., Hopkins P.N., Williams G.H., Pojoga L.H., Williams J.S. The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol. 2011;164(6):995–1002. https://doi.org/10.1530/EJE-11-0025..
DOI: 10.1530/EJE-11-0025

Васильева Л.В., Татаринцева Ю.В., Гостева Е.В., Попов С.Ю. Взаимосвязь артериальной гипертензии, метаболического синдрома с дефицитом витамина D у женщин. Актуальные проблемы медицины. 2020;43(4): 549–559. https://doi.org/10.18413/2687-0940-2020-43-4-549-559..
DOI: 10.18413/2687-0940-2020-43-4-549-559

Chapter 5. Dietary Reference Intakes for Adequacy: Calcium and Vitamin D. In: Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011, pp. 345–402. https://doi.org/10.17226/13050..
DOI: 10.17226/13050

Ovesen L., Brot C., Jakobsen J. Food contents and biological activity of 25-hydroxyvitamin D: a vitamin D metabolite to be reckoned with? Ann Nutr Metab. 2003;47(3–4):107–113. https://doi.org/10.1159/000070031..
DOI: 10.1159/000070031

Belenchia A.M., Tosh A.K., Hillman L.S., Peterson C.A. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr. 2013;97(4):774–781. https://doi.org/10.3945/ajcn.112.050013..
DOI: 10.3945/ajcn.112.050013

Ford A.R., Siegel M., Bagel J., Cordoro K.M., Garg A., Gottlieb A. et al. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: a Systematic Review. JAMA Dermatol. 2018;154(8):934–950. https://doi.org/10.1001/jamadermatol.2018.1412..
DOI: 10.1001/jamadermatol.2018.1412

Fu L.W., Vender R. Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome. Dermatol Res Pract. 2011;276079. https://doi.org/10.1155/2011/276079..
DOI: 10.1155/2011/276079

Lanham-New S.A., Buttriss J.L., Miles L.M., Ashwell M., Berry J.L., Boucher B.J. et al. Proceedings of the Rank Forum on Vitamin D. Br J Nutr. 2011;105(1):144–156. https://doi.org/10.1017/S0007114510002576..
DOI: 10.1017/S0007114510002576

Дедов И.И., Мельниченко Г.А., Белая Ж.Е., Дзеранова Л.К., Ильин А.В., Каронова Т.Л. и др. Дефицит витамина D у взрослых: клинические рекомендации. М.; 2016. 39 с. Режим доступа: https://rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdf.https://rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdf

Дедов И.И., Мельниченко Г.А., Белая Ж.Е., Дзеранова Л.К., Ильин А.В., Каронова Т.Л. и др. Дефицит витамина D у взрослых: клинические рекомендации. М.; 2016. 39 с. Режим доступа: https://rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdf.https://rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdf

Nowson C.A., McGrath J.J., Ebeling P.R., Haikerwal A., Daly R.M., Sanders K.M. et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust. 2012;196(11):686–687. https://doi.org/10.5694/mja11.10301..
DOI: 10.5694/mja11.10301

Płudowski P., Karczmarewicz E., Bayer M., Carter G., Chlebna-Sokół D., Czech-Kowalska J. et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319–327. https://doi.org/10.5603/ep.2013.0012..
DOI: 10.5603/ep.2013.0012

Aspray T.J., Bowring C., Fraser W., Gittoes N., Javaid M.K., Macdonald H. et al. National Osteoporosis Society vitamin D guideline summary. Age Ageing. 2014;43(5):592–595. https://doi.org/10.1093/ageing/afu093..
DOI: 10.1093/ageing/afu093

Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385..
DOI: 10.1210/jc.2011-0385

Cesareo R., Attanasio R., Caputo M., Castello R., Chiodini I., Falchetti A. et al. Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients. 2018;10(5):546. https://doi.org/10.3390/nu10050546..
DOI: 10.3390/nu10050546

Cowan A., Pugh R., McCaughey A. Treatment of Vitamin D Deficiency in Adults v0.4. MCGT. 2017. Available at: https://mm.wirral.nhs.uk/document_uploads/guidelines/Vitamin[%]20D[%]20Guidelines[%]20for[%]20Adults[%]20v2.pdf.https://mm.wirral.nhs.uk/document_uploads/guidelines/Vitamin[%]20D[%]20Guidelines[%]20for[%]20Adults[%]20v2.pdf

Cowan A., Pugh R., McCaughey A. Treatment of Vitamin D Deficiency in Adults v0.4. MCGT. 2017. Available at: https://mm.wirral.nhs.uk/document_uploads/guidelines/Vitamin[%]20D[%]20Guidelines[%]20for[%]20Adults[%]20v2.pdf.https://mm.wirral.nhs.uk/document_uploads/guidelines/Vitamin[%]20D[%]20Guidelines[%]20for[%]20Adults[%]20v2.pdf

Tripkovic L., Lambert H., Hart K., Smith C.P., Bucca G., Penson S. et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–1364. https://doi.org/10.3945/ajcn.111.031070..
DOI: 10.3945/ajcn.111.031070

Grossmann R.E., Tangpricha V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res. 2010;54(8):1055–1061. https://doi.org/10.1002/mnfr.200900578..
DOI: 10.1002/mnfr.200900578

Shab-Bidar S., Bours S., Geusens P.P., Kessels A.G., van den Bergh J.P. Serum 25(OH)D response to vitamin D3 supplementation: a meta-regression analysis. Nutrition. 2014;30(9):975–985. https://doi.org/10.1016/j.nut.2013.12.020..
DOI: 10.1016/j.nut.2013.12.020

Autier P., Gandini S., Mullie P. a systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab. 2012;97(8):2606–2613. https://doi.org/10.1210/jc.2012-1238..
DOI: 10.1210/jc.2012-1238

Zittermann A., Ernst J.B., Gummert J.F., Börgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr. 2014;53(2):367–374. https://doi.org/10.1007/s00394-013-0634-3..
DOI: 10.1007/s00394-013-0634-3